Award recordCONTRACT

PFIZER INC

PIID 36E79723A0023· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2023· $0 net obligations· UEI MHBQULRMEEJ5· NY

Description

BPA CANCELLATION

Base award description: BPA FOR OXYBRYTA

First action · last action
2023-09-26 · 2024-08-29
Transactions
4
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,300,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40269
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2023-09-26 · this action $0 · running total $0Modification P00001 · 2023-09-28 · this action $0 · running total $0Modification P00002 · 2023-12-29 · this action $0 · running total $0Modification P00003 · 2024-08-29 · this action $0 · running total $0
  • Base2023-09-26+$0= $0
  • Mod P000012023-09-28+$0= $0
  • Mod P000022023-12-29+$0= $0
  • Mod P000032024-08-29+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-09-26+$0$0BPA FOR OXYBRYTA
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-09-28+$0$0PRICE INCREASE ON TWO OXBRYTA NDCS
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-29+$0$02024 PUBLIC LAW PRICING UPDATES
Mod P00003· LEGAL CONTRACT CANCELLATION2024-08-29+$0$0BPA CANCELLATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MHBQULRMEEJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79725D0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0030NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C77024P0393NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$243,101FY2024
36F79724D0130NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C25024F0047250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$215,205FY2024
36E79720D0067NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2020

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79723A0023_3600 · retrieved 2026-09-26.